PharMaPe

Active

Private limited companyfounded 2024active for 2 yearsPettendonk 54, 2500 Lier, BelgiumKBO/BCE: BE 1005.186.155

Summary

PharMaPe has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €44,668 and a net result of €13,694. Its solvency ranks better than 66% of 9,615 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

PharMaPeActiveChecked score 97/100

Risk analysis Report Compare

History

On 25 January 2024, PharMaPe was incorporated as a private limited company by two natural persons, with a starting capital of €1,500.¹² PEETERS Margaux Guy Chris Ghislaine has served as director of the company since 2024.² The company has filed 2 sets of annual accounts, the latest for financial year 2025.³

Acts, filings and financial milestones

All 3Gazette 1Filings 2

Next filing, financial year 2026, expected by 31-07-2027

2026

06-07

NBB filing Annual accounts filed

financial year 2025 · micro format

2025

19-06

NBB filing Annual accounts filed

financial year 2024 · micro format

2024

29-01

Gazette deed Incorporation

Appointment: PEETERS Margaux Guy Chris Ghislaine (director) · Founder · Capital10 facts ▸

Incorporation, 24-01-2024
Founder, PEETERS Margaux Guy Chris Ghislaine
Capital
Pre-incorporation commitments, “takeover, alle handelingen verricht door oprichters in kader van voorwerp” (deed in Dutch)
Other provision, 29-12-2023
Other provision, “afwezigheid bestuursverbod, verklaring in volmacht waarmee oprichter wordt vertegenwoordigd” (deed in Dutch)
General meeting, “eerste algemene vergadering, oprichter” (deed in Dutch)
Board rule, 1, “aantal bestuurders vastgesteld op een” (deed in Dutch)
Director appointment, PEETERS Margaux Guy Chris Ghislaine (director)
Founding capital, €1,500

Gazette deedNBB filing

1 of 1 deed read